Page last updated: 2024-10-18

glycerol and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

glycerol has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies

Moon: The natural satellite of the planet Earth. It includes the lunar cycles or phases, the lunar month, lunar landscapes, geography, and soil.

Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yang, B1
Wang, C1
Xie, Y1
Xu, L1
Wu, X1
Wu, D1

Other Studies

1 other study available for glycerol and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
Monitoring tyrosine kinase inhibitor therapeutic responses with a panel of metabolic biomarkers in chronic myeloid leukemia patients.
    Cancer science, 2018, Volume: 109, Issue:3

    Topics: Biomarkers, Tumor; Drug Resistance, Neoplasm; Female; Gas Chromatography-Mass Spectrometry; Glycerol

2018